Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - April 2004

  1. Progress Toward Poliomyelitis Eradication--India, 2003. MMWR Morb.Mortal.Wkly.Rep.  53 (11): 238-241; March 26, 2004.

  2. School-Associated Pertussis Outbreak--Yavapai County, Arizona, September 2002-February 2003. MMWR Morb.Mortal.Wkly.Rep.  53 (10): 216-219; March, 2004.

  3. HHS-CDC NEWS: Update: Adverse Events Following Civilian Smallpox Vaccination--US, 2003. Ann.Pharmacother.  38 (4): 739; April, 2004.

  4. Andersen, T.  [Influenza Vaccination--One More Time]. Ugeskr.Laeger.  166 (7): 611-612; February 9, 2004.

  5. Bender, A.; Jager, G.; Scheuerer, W.; Feddersen, B.; Kaiser, R.; Pfister, H. W.  Two Severe Cases of Tick-Borne Encephalitis Despite Complete Active Vaccination-the Significance of Neutralizing Antibodies. J.Neurol.  251 (3): 353-354; March, 2004.

  6. Bozza, S.; Montagnoli, C.; Gaziano, R.; Rossi, G.; Nkwanyuo, G.; Bellocchio, S.; Romani, L.  Dendritic Cell-Based Vaccination Against Opportunistic Fungi. Vaccine.  22 (7): 857-864; February 17, 2004.

  7. Brinkman, D. M.; Jol-van der Zijde, C. M.; ten Dam, M. M.; Vossen, J. M.; Osterhaus, A. D.; Kroon, F. P.; van Tol, M. J.  Vaccination With Rabies to Study the Humoral and Cellular Immune Response to a T-Cell Dependent Neoantigen in Man. J.Clin.Immunol.  23 (6): 528-538; November, 2003.

  8. Buff, A. M.; Welch, F. J.; Tapia, R. A.  A Review of Varicella Vaccine and Louisiana Vaccination Requirements. J.La State Med.Soc.  156 (1): 50-55; January, 2004.

  9. Butler, D.  Nigerian States Disrupt Campaign to Eradicate Polio. Nature.  428 (6979): 109; March 11, 2004.

  10. Butler, J. R.; McIntyre, P.; MacIntyre, C. R.; Gilmour, R.; Howarth, A. L.; Sander, B.  The Cost-Effectiveness of Pneumococcal Conjugate Vaccination in Australia. Vaccine.  22 (9-10): 1138-1149; March 12, 2004.

  11. Clemetson, C. A.  Elevated Blood Histamine Caused by Vaccinations and Vitamin C Deficiency May Mimic the Shaken Baby Syndrome. Med.Hypotheses.  62 (4): 533-536; 2004.

  12. Clemetson, C. A.  Individual Reactions Following Vaccinations or Inoculations Are Highly Variable. Mil.Med.  169 (2): v; February, 2004.

  13. Crittenton, E.; Davis, A.; Hoffmann, K. K.; Rutala, W. A.; Weber, D. J.  Semipermeable Dressing Used to Cover Smallpox Vaccination Sites As a Cause of Skin Damage. Infect.Control Hosp.Epidemiol.  25 (2): 96; February, 2004.

  14. Cunha, S. C.; Dourado, I.  MMR Mass Vaccination Campaigns, Vaccine-Related Adverse Events, and the Limits of the Decision Making Process, in Brazil. Health Policy.  67 (3): 323-328; March, 2004.

  15. Deng, Y.; Jing, Y.; Campbell, A. E.; Gravenstein, S.   Age-Related Impaired Type 1 T Cell Responses to Influenza: Reduced Activation Ex Vivo, Decreased Expansion in CTL Culture in Vitro, and Blunted Response to Influenza Vaccination in Vivo in the Elderly. J.Immunol.  172 (6): 3437-3446; March 15, 2004.

  16. Evans, C. T.; Legro, M. W.; Weaver, F. M.; Goldstein, B.  Influenza Vaccination Among Veterans With Spinal Cord Injury: Part 1. A Survey of Attitudes and Behavior. J.Spinal Cord.Med.  26 (3): 204-209; 2003.

  17. Farrington, C. P.  Re: "Risk Analysis of Aseptic Meningitis After Measles-Mumps-Rubella Vaccination in Korean Children by Using a Case-Crossover Design". Am.J.Epidemiol.  159 (7): 717-718; April 1, 2004.

  18. Filippis, A. M.; Nogueira, R. M.; Jabor, A. V.; Schatzmayr, H. G.; Oliveira, J. C.; Dinis, S. C.; Galler, R.  Isolation and Characterization of Wild Type Yellow Fever Virus in Cases Temporally Associated With 17DD Vaccination During an Outbreak of Yellow Fever in Brazil. Vaccine.  22 (9-10): 1073-1078; March 12, 2004.

  19. Fleck, F.  Nigerian President Holds Key to Global Polio Eradication. BMJ.  328 (7439): 544; March 6, 2004.

  20. Goldstein, B.; Hammond, M. C.  The Importance of Influenza Vaccinations in Persons With Spinal Cord Injury and Disease. J.Spinal Cord.Med.  26 (3): 219-220; 2003.

  21. Greenberg, R. N.; Schosser, R. H.; Plummer, E. A.; Roberts, S. E.; Caldwell, M. A.; Hargis, D. L.; Rudy, D. W.; Evans, M. E.; Hopkins, R. J.  Urticaria, Exanthems, and Other Benign Dermatologic Reactions to Smallpox Vaccination in Adults. Clin.Infect.Dis.  38 (7): 958-965; April 1, 2004.

  22. Gunn, S. W.  Vaccination. World J.Surg.  March 17, 2004. [Epub ahead of print].

  23. 23. Hamilton, M.; Corwin, P.; Gower, S.; Rogers, S.  Why Do Parents Choose Not to Immunise Their Children? N.Z.Med.J.  117 (1189): U768; February, 2004.

  24. Husain, S.; Slobodkin, D.; Weinstein, R. A.  Corrections to Table. Arch.Intern.Med.  164 (5): 573; March 8, 2004.

  25. Ivers, L. C.; Ryan, E. T.  Vaccination Strategies. Clin.Occup.Environ.Med.  4 (1): 27-43; February, 2004.

  26. Jack, S.  Review: Existing Epidemiological Evidence Does Not Show an Association Between Mumps, Measles, and Rubella Vaccination and Autism. Evid.Based.Nurs.  7 (1): 25; January, 2004.

  27. Jelleyman, T.; Ure, A.  Attitudes to Immunisation: a Survey of Health Professionals in the Rotorua District. N.Z.Med.J.  117 (1189): U769; February, 2004.

  28. John, T. J.  The Golden Jubilee of Vaccination Against Poliomyelitis. Indian J.Med.Res.  119:1-17; January, 2004.

  29. Kaplan, S. L.; Mason, E. O., Jr.; Wald, E. R.; Schutze, G. E.; Bradley, J. S.; Tan, T. Q.; Hoffman, J. A.; Givner, L. B.; Yogev, R.; Barson, W. J.  Decrease of Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States After the Introduction of the 7-Valent Pneumococcal Conjugate Vaccine. Pediatrics.  113 (3 Pt 1): 443-449; March, 2004.

  30. Kapp, C.  Nigerian States Again Boycott Polio-Vaccination Drive. Muslim Officials Have Rejected Assurances That the Polio Vaccine Is Safe--Leaving Africa on the Brink of Reinfection. Lancet.  363 (9410): 709; February 28, 2004.

  31. Kelly, C. D.; Egan, C.; Davis, S. W.; Samsonoff, W. A.; Musser, K. A.; Drabkin, P.; Miller, J. R.; Taylor, J.; Cirino, N. M.  Laboratory Confirmation of Generalized Vaccinia Following Smallpox Vaccination. J.Clin.Microbiol.  42 (3): 1373-1375; March, 2004.

  32. Korczowski, B.  Procalcitonin and C-Reactive Protein in Vaccination-Associated Adverse Reactions. Pediatr.Infect.Dis.J.  23 (3): 283; March, 2004.

  33. LeBaron, C. W.; Starnes, D. M.; Rask, K. J.  The Impact of Reminder-Recall Interventions on Low Vaccination Coverage in an Inner-City Population. Arch.Pediatr.Adolesc.Med.  158 (3): 255-261; March, 2004.

  34. Madjid, M.; Casscells, W.  Influenza As a Bioterror Threat: the Need for Global Vaccination. Expert.Opin.Biol.Ther.  4 (3): 265-267; March, 2004.

  35. Mahan, C. M.; Kang, H. K.; Dalager, N. A.; Heller, J. M.  Anthrax Vaccination and Self-Reported Symptoms, Functional Status, and Medical Conditions in the National Health Survey of Gulf War Era Veterans and Their Families. Ann.Epidemiol.  14 (2): 81-88; February, 2004.

  36. Maitra, A.; Sherriff, A.; Griffiths, M.; Henderson, J.; Avon Longitudinal Study Of Parents And Children Study Team  Pertussis Vaccination in Infancy and Asthma or Allergy in Later Childhood: Birth Cohort Study. BMJ.  March, 2004. [Epub ahead of print].

  37. Manthey, D. E.; Stopyra, J.; Askew, K.  Referral of Emergency Department Patients for Pneumococcal Vaccination. Acad.Emerg.Med.  11 (3): 271-275; March, 2004.

  38. 38. May, T.; Silverman, R. D.; Aulisio, M. P.  Do Healthcare Professionals Have an Obligation to Be Vaccinated Against Smallpox? APA.Newsl.Philos.Med.  2 (2): 209-212; 2003.

  39. 39. Miller, G. E.; Cohen, S.; Pressman, S.; Barkin, A.; Rabin, B. S.; Treanor, J. J.  Psychological Stress and Antibody Response to Influenza Vaccination: When Is the Critical Period for Stress, and How Does It Get Inside the Body? Psychosom.Med.  66 (2): 215-223; March, 2004.

  40. Millett, P. D.  Proliferation of Biological Weapons: Challenges and Responses. Med.Confl.Surviv.  20 (1): 4-18; January, 2004.

  41. Pasquarella, A.; Perria, C.; D'Amato, M.; Billi, P.; Marceca, M.; Volpe, E.; Guasticchi, G.  [Management of Vaccination Practices in Adults: the Influenza Vaccination Campaign in Lazio Region, Italy]. Ann.Ig.  15 (6): 871-879; November, 2003.

  42. Paul, Y.  Setback in Polio Eradication in India in 2002: Reasons and Remedies. Indian Pediatr.  41 (2): 202-203; February, 2004.

  43. Petrie, K. J.; Moss-Morris, R.; Grey, C.; Shaw, M.  The Relationship of Negative Affect and Perceived Sensitivity to Symptom Reporting Following Vaccination. Br.J.Health Psychol.  9 (Pt 1): 101-111; February, 2004.

  44. Pierrynowski-Gallant, D. M.; Vollman, A. R.  Influenza Vaccination Choices. Can.Nurse.  100 (2): 16-21; February, 2004.

  45. Puvacic, S.; Mulaomerovic, M.; Karakas, S.; Tandir, S.; Nada, E.  [Expected Incidence of Post-Vaccination Complications in Vaccination Programs]. Med.Arh.  57 (5-6): 269-272; 2003.

  46. 46. Pywell, S.  Vaccination and Other Altruistic Medical Treatments: Should Autonomy or Communitarianism Prevail? Med.Law Int.  4 (3-4): 223-243; 2000.

  47. Schwartz, M.  Protective Autoimmunity and Prospects for Therapeutic Vaccination Against Self-Perpetuating Neurodegeneration. Ernst.Schering.Res.Found.Workshop.47): 133-154; 2004.

  48. Sharma, M. K.; Bhatia, V.; Swami, H. M.  Outbreak of Measles Amongst Vaccinated Children in a Slum of Chandigarh. Indian J.Med.Sci.  58 (2): 47-53; February, 2004.

  49. Shetty, P.  Weapons of Mass Vaccination. Lancet Infect.Dis.  4 (3): 129; March, 2004.

  50. Stuck, B.  [Vaccination Complacency. How to Overcome Your Patient's Skepticism and Strengthen His Motivation]. MMW.Fortschr.Med.  145 (45): 25; November 6, 2003.

  51. Tam, T.; Langley, J.  An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: Statement on Influenza Vaccination for the 2003-04 Season. Can.Commun.Dis.Rep.  30:1-5; March 1, 2004.

  52. Tugwell, B. D.; Lee, L. E.; Gillette, H.; Lorber, E. M.; Hedberg, K.; Cieslak, P. R.  Chickenpox Outbreak in a Highly Vaccinated School Population. Pediatrics.  113 (3 Pt 1): 455-459; March, 2004.

  53. Turner, N.  Concerns of Health Providers and Parents Affect Immunisation Coverage. N.Z.Med.J.  117 (1189): U766; February, 2004.

  54. Utz, S.; Richard, J. L.; Capaul, S.; Matter, H. C.; Hrisoho, M. G.; Muhlemann, K.  Phylogenetic Analysis of Clinical Mumps Virus Isolates From Vaccinated and Non-Vaccinated Patients With Mumps During an Outbreak, Switzerland 1998-2000. J.Med.Virol.  73 (1): 91-96; May, 2004.

  55. van Neerven, R. J.; Arvidsson, M.; Ipsen, H.; Sparholt, S. H.; Rak, S.; Wurtzen, P. A.  A Double-Blind, Placebo-Controlled Birch Allergy Vaccination Study: Inhibition of CD23-Mediated Serum-Immunoglobulin E-Facilitated Allergen Presentation. Clin.Exp.Allergy.  34 (3): 420-428; March, 2004.

  56. Vincents, G.  [Influenza Vaccination]. Ugeskr.Laeger.  166 (7): 612; February 9, 2004.

  57. Walker, R. I.; Blanchard, T.; Braun, J. M.; Cebra, J. J.; Cross, A. S.; Fattom, A.; Giannasca, P. J.; Holder, I. A.; Huebner, J.; Matthews, R.; Pier, G. B.; Romani, L.; von Specht, B. U.; Trautmann, M.  Meeting Summary: Possibilities for Active and Passive Vaccination Against Opportunistic Infections. Vaccine.  22 (7): 801-804; February 17, 2004.

  58. Way, A. B.  Choices About Meningococcal Vaccination. N.Engl.J.Med.  350 (11): 1156; March 11, 2004.

  59. Weaver, F. M.; Goldstein, B.; Evans, C. T.; Legro, M. W.; LaVela, S.; Smith, B.; Miskevics, S.; Hammond, M. C.  Influenza Vaccination Among Veterans With Spinal Cord Injury: Part 2. Increasing Vaccination Rates. J.Spinal Cord.Med.  26 (3): 210-218; 2003.

  60. Wright, S. A.; Taggart, A. J.  Pneumococcal Vaccination for RA Patients on TNF-{Alpha} Antagonists. Rheumatology.(Oxford).  43 (4): 523; April, 2004.

  61. Young, D. C.  Smallpox Vaccination in the Shadow of Jenner. Lancet.  363 (9410): 738; February 28, 2004.

  62. Zangwill, K. M.; Belshe, R. B.  Safety and Efficacy of Trivalent Inactivated Influenza Vaccine in Young Children: a Summary for the New Era of Routine Vaccination. Pediatr.Infect.Dis.J.  23 (3): 189-197; March, 2004.

Back to Top